INST synthesizes hybrid compound that can inhibit Cancer cells

▴ INST comes up with Cancer inhibiting chemicals
INST synthesizes inorganic-organic hybrid compound that can inhibit breast, lung & liver cancer cells

Scientists from the Institute of Nano Science & Technology (INST), Mohali, an autonomous institute of the Department of Science and Technology Government of India, have synthesized a novel inorganic-organic hybrid compound that can inhibit breast, lung, and liver cancer cells, opening up new possibilities for metallodrugs.

The solid compound based on phosphomolybdate cluster, an inorganic salt of phosphomolybdic acid, belongs to the Polyoxometalates (POMs) family, which had earlier been identified to have antitumor potential. The team of scientists led by Dr. Monika Singh and Dr. Deepika Sharma has chalked out the mechanism by which the compound kills the cancer cells. The research has been published in the journal Dalton Transactions.

POMs are an evolving class of inorganic metal oxides, which over the last decades, established promising biological activities by the virtue of their great diversity in structures and properties.

In order to probe into the mechanism of how the cancer cells are attacked by the compound, the team synthesized it by hydrothermal method. The aqueous mixture of sodium molybdate, phosphorus acid, and bipyridine was heated in an acetate buffer solution of pH 4 at 160 °C for 72 hours. In vitro cytotoxicity of the compound was determined on breast cancer (MCF-7), lung cancer (A549) and liver cancer (HepG2) cells by the conventional MTT assay (used for assessing cell metabolic activity). The cytotoxic effect observed for the compound on the various cancer cell lines was further compared with that of a routinely used chemotherapeutic agent, Methotrexate (TCI), by the MTT assay.

The mechanism of cell death occurring in breast cancer (MCF-7), lung cancer (A549) and liver cancer (HepG2) cells were evaluated using an Alexa Fluor 488 annexin V/dead cell apoptosis kit (Invitrogen). To determine the effect of the synthesized materials on the cell division, cell cycle analysis for the MCF-7, A549, and HepG2 cell lines was done by using flow cytometry. The in vitro results showed that this hybrid solid is less toxic towards normal cells, and its antitumor activity was also found to be comparable with that of a routinely used chemotherapeutic agent, Methotrexate (MTX).

In the past few decades, POMs have evolved as a promising candidate for future metallodrugs for combating cancer. The compound synthesized by the INST team could open new avenues for antitumor applications.

Tags : #PhosphomolybdateCluster #INSTMohali #BreastCancer #LungCancer #CancerCells

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

CSIR and Laxai Sciences partners for COVID clinical trialsJuly 08, 2020
Tech Mahindra's, Bhubaneswar office sealed ; COVID-19 cases detectedJuly 08, 2020
India might see 2.87 lakh Covid cases per day by February 2021 : MIT July 08, 2020
Assam: Total coronavirus cases at 13,336; death toll 16July 08, 2020
PHC Group increases stake in SciMed to strengthen business in AsiaJuly 07, 2020
“We cannot let the pandemic stop us”; Dr. Harsh VardhanJuly 07, 2020
Merck Foundation provided oncology training to African doctorsJuly 07, 2020
Johns Hopkins reports promising clinical data in COVID-19 ARDSJuly 07, 2020
Masks encouraged next Trump rally, says White HouseJuly 07, 2020
Life-Saving HIV drugs risk running out as COVID-19 hits supplies-WHO July 07, 2020
Beijing reports zero Coronavirus casesJuly 07, 2020
One of the first for clinical trial for COVID-19 vaccineJuly 07, 2020
Australia's second-biggest city under new coronavirus lockdownJuly 07, 2020
A temple offers pandemic-hit Vietnamese workersJuly 07, 2020
Harvard, Princeton to reopen, many students barred from campus housingJuly 07, 2020
Atlanta mayor tests positive for CoronavirusJuly 07, 2020
Boris Johnson under fire for home deaths blame gameJuly 07, 2020
View mask refusers like drunk drivers: leading scientistJuly 07, 2020
Mankind Pharma promotes ‘Atmanirbhar Bharat’ with new Anthem July 07, 2020
Health and nutrition in young women: preparing for next generationJuly 07, 2020